biotech2 min read
Human cell programming company bit.bio closes $25M Series D
Human cell programming company bit.bio has secured $25million in Series D funding to expand its portfolio of human cell models andincrease access to its technology for pharmaceutical companies, biotec...
By Tamara DjurickovicTech.eu

Read the full story
Originally published by Tech.eu on Nov 4, 2026.
Comments
Sign in to join the discussion.